TrialEuropean journal of clinical pharmacology2010

Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients.

Katrijn Bogman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.